Signing ceremony

　　On September 11th, at the headquarters of Shenzhen Nanshan International E Park Green Leopard Medical Group, Liu Xiaoqing (Chairman of Shenzhen Green Leopard Medical Technology Co., Ltd.) and Fu Wenxing (Chief Strategy Planner of Kaifeng Jiufulai Biotechnology Co., Ltd.) sign Health Product Development and PMAS Cancer Treatment Clinical Application Strategic Cooperation Agreement. The two parties will jointly develop a full range of products for the overall health care solution. The agreement also stipulates that Green Leopard Medical will take the lead and use its rich medical resources to assist the clinical application of the “PMAS” biological agent of Jufeel Company in not less than 50 secondary level hospitals within two years. According to the clinical results, the relevant important clinical academic papers will be published, and the implementation of the "PMAS" clinical drug number will be implemented as soon as possible.

　　In March of this year, Green Leopard Medical and Jufeel Biotechnology has reached cooperation with 1300 domestic hospitals in "Hu Wa Intelligent Pharmacy Platform" of Green Leopard Medical for Jufeel's highly popular product " PMAS" sales. After half a year of running-in, the sales performance of each other has improved significantly.

　　Established in 2013, Green Leopard Medical is a national medical high-tech enterprise integrating life science and technology, medical drugs and extension products, intelligent equipment manufacturing and intelligent software R&D, production and market operation. The Green Leopard Group currently has 23 provincial branch offices. Its independently developed “Hu Wa Smart Pharmacy” has nearly 100 patents and dozens of software copyrights. It has already been settled in 1,300 hospitals in China and has more than 60 out-of-hospital clinical exclusive product. After five years of development, Green Leopard Medical has formed three core advantages of “Intelligent Device Hardware Manufacturing, Medical Software Independent R&D, Hospital Smart Pharmacy Platform Operation”, and has realised rapidly development trend of four-in-one strategy of“Hospital New Retail, Hospital New Media, Internet Medical, and Civil Health Big Data”

　　PMAS is a patented product of Jufeel Biotechnology, which has been purified from Aloe Vera at 10000/1.5 ratio and has been developed and researched for 19 years. It is mainly used in the three major fields of human immune system repair and reconstruction, cancer rehabilitation and human sex hormone secretion. In 2016, the auxiliary drug number of PMAS for the treatment of immune diseases and tumor rehabilitation is obtained in Tanzania, East Africa; in 2017, it wins the “Aloe Black Technology Gold Award” in Thailand Expo; in the same year, the United Nations World AIDS Organization (WAOUN) awards“The World Outstanding AIDS Prevention and Treatment Award"; in April 2018, the 46th Swiss Geneva Technology Expo Medical Health Gold Award is awarded; at the 20th International Conference on STD-AIDS AND INFECTIOUS DISEASES, PMAS wins the honorary certificate jointly awarded by the world's three prestigious universities, the University of Oxford, the University of Strasbourg, France, and the University of California. The PMAS has won numerous awards in the international society, and it has become famous and has attracted wide attention in the industry.

　　It is understood that the Green Leopard Medical and Jufeel Biotechnology also jointly develop new biological agents for the treatment of cardiovascular, papillomavirus HPV, cervical cancer and anti-Helicobacter pylori, and reach a joint development cooperation.